| 
									Ä«Å×°í¸®
								 | 
				
					                                                    Others
                                            				 | 
			 
									
				| 
									CAT.NO
								 | 
				
					                                                    LGP-60-018
                                            				 | 
			 
									
				| 
									PRODUCT
								 | 
				
					                                                    Recombinant Human Thymosin beta 4
                                            				 | 
			 
									
				| 
									SIZE
								 | 
				
					                                                    100ug, 500ug, 1mg
                                            				 | 
			 
									
				| 
									PRICE
								 | 
				
					                                                    KRW 285,000, 940,000, 1,560,000
                                            				 | 
			 
					
		
			
				
					Technical Parameters 
| Synonyms | 
Fx |  
| Accession | 
P62328 |  
| GeneID | 
7114 |  
| Source | 
Escherichia coli. |  
| Molecular Weight | 
Approximately 4.9 kDa, a single non-glycosylated polypeptide chain containing 43 amino acids. |  
| Quantity | 
100µg/500µg/1000µg |  
| AA Sequence | 
SDKPDMAEIE KFDKSKLKKT ETQEKNPLPS KETIEQEKQA GES |  
| Purity | 
> 97 % by SDS-PAGE and HPLC analyses. |  
| Biological Activity | 
Fully biologically active when compared to standard. The biological activity determined by its ability to produce a protective effect against hydrogen peroxide in primary lung fibroblasts is in a concentration range of 0.5 - 10 ¥ìg/ml. |  
| Physical Appearance | 
Sterile Filtered White lyophilized (freeze-dried) powder. |  
| Formulation | 
Lyophilized from a 0.2 µm filtered concentrated solution in 20 mM PB, pH 7.4. |  
| Endotoxin | 
Less than 1 EU/µg of rHuT¥â4 as determined by LAL method. |  
| Reconstitution | 
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ¡Â -20 ¡ÆC. Further dilutions should be made in appropriate buffered solutions. |  
| Stability & Storage | 
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. - 12 months from date of receipt, -20 to -70 ¡ÆC as supplied. - 1 month, 2 to 8 ¡ÆC under sterile conditions after reconstitution. - 3 months, -20 to -70 ¡ÆC under sterile conditions after reconstitution. |  
| Usage | 
This material is offered by Korea Lugen Sci for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE. |  
| SDS-PAGE | 
  |  
| Reference | 
1. Moon EY, Song JH, Yang KH. 2007. Oncol Res, 16: 507-16. 2. Oh SY, Song JH, Gil JE, et al. 2006. Exp Cell Res, 312: 1651-7. 3. Oh JM, Ryoo IJ, Yang Y, et al. 2008. Cancer Lett, 264: 29-35. |  
| Background | 
Thymosin Beta 4 is a naturally occurring peptide encoded by the TMSB4X gene located on Chr. X in humans. It is found in high concentrations in blood platelets, wound fluid and other tissues in the body. T¥â-4 is a major actin regulating peptide and the primary function is to stimulate the productions of T cells, which plays important part of the immune system. The thymosin beta-4 peptide, if used after a heart attack, might reactivate cardiac progenitor cells to repair damaged heart tissue. |    
				 
				
			 | 
		 
						
			
				| 
											÷ºÎÆÄÀÏ
									 | 
				
					
										
				 | 
			 
			
			
   
    
   
   
   
   
   
   
   
   
   
   
   
   
   
   
    
     | 
     
      
     
      | 
     
       
       
        
       
       
        
      | 
     
    
   |